We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$2.25B
AUM Growth
+$405M
Cap. Flow
+$2.31B
Cap. Flow %
102.69%
Top 10 Hldgs %
14.53%
Holding
1,145
New
406
Increased
187
Reduced
178
Closed
367

Sector Composition

Rank Sector Weight
1 Healthcare 22.31%
2 Consumer Discretionary 16.07%
3 Industrials 13.87%
4 Technology 11.32%
5 Financials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBIX icon
101
Neurocrine Biosciences
NBIX
$16.8B
$6.15M 0.27%
50,000
-5,000
-9% -$567K
DLR icon
102
Digital Realty Trust
DLR
$70.5B
$6.11M 0.27%
+54,100
New +$6.48M
CSTM icon
103
Constellium
CSTM
$3.76B
$6.09M 0.27%
493,100
+219,000
+80% +$2.56M
PLNT icon
104
Planet Fitness
PLNT
$4.39B
$6M 0.27%
+111,100
New +$5.52M
MDR
105
DELISTED
McDermott International
MDR
$5.98M 0.27%
+324,600
New +$6.07M
CTOS icon
106
Custom Truck One Source
CTOS
$2.31B
$5.95M 0.26%
+600,000
New +$5.92M
V icon
107
Visa
V
$682B
$5.91M 0.26%
39,356
-83,522
-68% -$11.9M
ALDR
108
DELISTED
Alder Biopharmaceuticals
ALDR
$5.89M 0.26%
353,700
+276,700
+359% +$5M
SYNH
109
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$5.83M 0.26%
113,100
+12,300
+12% +$602K
SNPS icon
110
Synopsys
SNPS
$73.5B
$5.83M 0.26%
59,076
-2,418
-4% -$230K
ALNY icon
111
Alnylam Pharmaceuticals
ALNY
$27.2B
$5.82M 0.26%
66,500
PETQ
112
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$5.8M 0.26%
+147,700
New +$4.91M
HLF icon
113
Herbalife
HLF
$1.27B
$5.8M 0.26%
+106,400
New +$5.88M
DRI icon
114
Darden Restaurants
DRI
$23.4B
$5.79M 0.26%
52,100
-23,400
-31% -$2.64M
CCI icon
115
Crown Castle
CCI
$32.9B
$5.79M 0.26%
+52,000
New +$5.79M
ALXN
116
DELISTED
Alexion Pharmaceuticals
ALXN
$5.73M 0.25%
41,200
+6,200
+18% +$778K
NRG icon
117
NRG Energy
NRG
$28.1B
$5.54M 0.25%
148,000
+96,400
+187% +$3.23M
ADM icon
118
Archer Daniels Midland
ADM
$38.6B
$5.54M 0.25%
+110,100
New +$5.4M
TT icon
119
Trane Technologies
TT
$101B
$5.54M 0.25%
54,100
-57,100
-51% -$5.58M
CNP icon
120
CenterPoint Energy
CNP
$27.9B
$5.53M 0.25%
200,000
+109,672
+121% +$3.07M
WBT
121
DELISTED
Welbilt, Inc.
WBT
$5.46M 0.24%
261,385
+244,095
+1,412% +$5.38M
VALE icon
122
Vale
VALE
$63.2B
$5.42M 0.24%
+365,200
New +$4.93M
EXEL icon
123
Exelixis
EXEL
$13.4B
$5.36M 0.24%
302,400
+77,400
+34% +$1.51M
DXCM icon
124
DexCom
DXCM
$32B
$5.28M 0.23%
147,600
+113,960
+339% +$3.53M
VCEL icon
125
Vericel Corp
VCEL
$2.32B
$5.26M 0.23%
371,600
-153,400
-29% -$1.8M

Similar funds

Schonfeld Strategic Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Schonfeld Strategic Advisors held 1,145 positions worth $2.25B, up 22% from $1.84B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Schonfeld Strategic Advisors deployed $2.31B of net new capital in Q3 2018, opening 406 new positions and adding to 187 existing holdings. Its largest new stake was Fortive: 632,433 shares worth $33.6M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Equitable Holdings, an estimated $22.7M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2018 buy was Fortive: 632,433 shares worth $33.6M.
  • Schonfeld Strategic Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $93.2M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2018 reduction was Equitable Holdings, cutting an estimated $22.7M.
  • Schonfeld Strategic Advisors fully exited Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00 in Q3 2018, selling an estimated $22.4M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 15% of its $2.25B portfolio in Q3 2018.
  • Schonfeld Strategic Advisors opened 406 new positions and closed 367 in Q3 2018.
  • Schonfeld Strategic Advisors's portfolio value rose 22% quarter-over-quarter to $2.25B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.